Clinical utility and implementation of genomic newborn screening: findings from the SNUseq Baby Project.
Genomic newborn screening (NBS) has emerged as a powerful complement to conventional screening; however, its clinical utility remains to be fully established. We conducted a prospective multicenter pilot study within the Seoul National University Hospital network from November 2025 to February 2026. A panel of 419 gene...